What to expect when you take Incruse ellipta and Saeng-ji-whang?

Do you take Incruse ellipta and Saeng-ji-whang? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.



On Mar, 19, 2019

71 reports have been studied.


Females aged 50 to 59 :

36 related reports were analyzed:

Most common symptoms:

Chest pain
  • 13.89% for females aged 50 (±5) who take Incruse ellipta

Most common co-existing conditions:

Asthma
  • 13.89% for females aged 50 (±5) who take Incruse ellipta
Chronic obstructive pulmonary disease
  • 33.33% for females aged 50 (±5) who take Incruse ellipta
Dyspnea
  • 13.89% for females aged 50 (±5) who take Incruse ellipta
back to top

Males aged 50 to 59 :

35 related reports were analyzed:

Most common symptoms:

Dyspnea
  • 22.86% for males aged 50 (±5) who take Incruse ellipta

Most common co-existing conditions:

Chronic obstructive pulmonary disease
  • 45.71% for males aged 50 (±5) who take Incruse ellipta
back to top

Do you take Incruse ellipta and Saeng-ji-whang:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

Incruse ellipta

Incruse ellipta has active ingredients of umeclidinium bromide. (latest outcomes from Incruse ellipta 2,490 users)

Saeng-ji-whang

Saeng-ji-whang has active ingredients of rehmannia.

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.